Literature DB >> 28588795

Cancer survival in Qidong between 1972 and 2011: A population-based analysis.

Jian-Guo Chen1,2, Jian Zhu1, Yong-Hui Zhang1, Yi-Xin Zhang2, Deng-Fu Yao3, Yong-Sheng Chen1, Jian-Hua Lu1, Lu-Lu Ding1, Hai-Zhen Chen2, Chao-Yong Zhu2, Li-Ping Yang2, Yuan-Rong Zhu1, Fu-Lin Qiang2.   

Abstract

Population-based cancer survival is an improved index for evaluating the overall efficiency of cancer health services in a given region. The current study analysed the observed survival and relative survival of leading cancer sites from a population-based cancer registry between 1972 and 2011 in Qidong, China. A total of 92,780 incident cases with cancer were registered and followed-up for survival status. The main sites of the cancer types, based on the rank order of incidence, were the liver, stomach, lung, colon and rectum, oesophagus, breast, pancreas, leukaemia, brain and central nervous system (B and CNS), bladder, blood [non-Hodgkin's lymphoma (NHL)] and cervix. For all malignancies combined, the 5-year observed survival was 13.18% and the relative survival was 15.80%. Females had higher observed survival and relative survival (19.32 and 22.71%, respectively) compared with males (9.63 and 11.68%, respectively). The cancer sites with the highest five-year relative survival rates were the female breast, bladder, cervix and colon and rectum; followed by NHL, stomach, B and CNS cancer and leukaemia. The poorest survival rates were cancers of oesophagus, lung, pancreas and liver. Higher survival rates were observed in younger patients compared with older patients. Cancers of the oesophagus, female breast and bladder were associated with higher survival in middle-aged groups. Improved survival rates in the most recent two 5-year calendar periods were identified for stomach, lung, colon and rectum, oesophagus, female breast and bladder cancer, as well as leukaemia and NHL. The observations of the current study provide the opportunity for evaluation of the survival outcomes of frequent cancer sites that reflects the changes and improvement in a rural area in China.

Entities:  

Keywords:  epidemiology; neoplasm; observed survival; population-based cancer registration; relative survival

Year:  2017        PMID: 28588795      PMCID: PMC5451853          DOI: 10.3892/mco.2017.1234

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  65 in total

1.  Proposal for a cooperative study on population-based cancer survival in selected registries in East Asia.

Authors:  Hideo Tanaka; Masahiro Tanaka; Wanqing Chen; Sohee Park; Kyu-Won Jung; Chun-Ju Chiang; Mei-Shu Lai; Maria Rica Mirasol-Lumague; Adriano S Laudico; Evlena Suzanna Sinuraya; Yoshikazu Nishino; Akiko Shibata; Manabu Fujita; Midori Soda; Michiko Naito; Hideaki Tsukuma; Malcolm A Moore; Wakiko Ajiki
Journal:  Asian Pac J Cancer Prev       Date:  2009

2.  [Cancer Survival between 1995 and 2004 in the Basque Country, Spain].

Authors:  Mónica Machón Sobrado; Imanol Mozo Carollo; María-Crescencia Tobalina Gómez; Visitación de Castro Laiz; Ruth Martínez Cobo; Isabel Izarzugaza Lizarraga; Nerea Larrañaga Larrañaga
Journal:  Rev Esp Salud Publica       Date:  2012 May-Jun

3.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

4.  Cancer survival differences between European countries and an urban population from the Philippines.

Authors:  Maria Theresa Redaniel; Adriano Laudico; Maria Rica Mirasol-Lumague; Adam Gondos; Hermann Brenner
Journal:  Eur J Public Health       Date:  2010-04-21       Impact factor: 3.367

5.  Cancer survival in Africa, Asia, and Central America: a population-based study.

Authors:  Rengaswamy Sankaranarayanan; Rajaraman Swaminathan; Hermann Brenner; Kexin Chen; Kee Seng Chia; Jian Guo Chen; Stephen C K Law; Yoon-Ok Ahn; Yong Bing Xiang; Balakrishna B Yeole; Hai Rim Shin; Viswanathan Shanta; Ze Hong Woo; Nimit Martin; Yupa Sumitsawan; Hutcha Sriplung; Adolfo Ortiz Barboza; Sultan Eser; Bhagwan M Nene; Krittika Suwanrungruang; Padmavathiamma Jayalekshmi; Rajesh Dikshit; Henry Wabinga; Divina B Esteban; Adriano Laudico; Yasmin Bhurgri; Ebrima Bah; Nasser Al-Hamdan
Journal:  Lancet Oncol       Date:  2009-12-10       Impact factor: 41.316

6.  Surgical treatment of early stage breast cancer in elderly: an international comparison.

Authors:  M Kiderlen; E Bastiaannet; P M Walsh; N L Keating; S Schrodi; J Engel; W van de Water; S M Ess; L van Eycken; A Miranda; L de Munck; C J H van de Velde; A J M de Craen; G J Liefers
Journal:  Breast Cancer Res Treat       Date:  2011-11-27       Impact factor: 4.872

7.  Imputation of missing values of tumour stage in population-based cancer registration.

Authors:  Nora Eisemann; Annika Waldmann; Alexander Katalinic
Journal:  BMC Med Res Methodol       Date:  2011-09-19       Impact factor: 4.615

8.  Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan.

Authors:  Chia-Yen Huang; Chi-An Chen; Yu-Li Chen; Chun-Ju Chiang; Tsui-Hsia Hsu; Ming-Chieh Lin; Mei-Shu Lai; Chien-Jen Chen; San-Lin You; Wen-Fang Cheng
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

9.  Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: a population-based study.

Authors:  Renata Abrahão; Ruth H Keogh; Daphne Y Lichtensztajn; Rafael Marcos-Gragera; Bruno C Medeiros; Michel P Coleman; Raul C Ribeiro; Theresa H M Keegan
Journal:  Br J Haematol       Date:  2016-02-05       Impact factor: 8.615

10.  Hospital-based colorectal cancer survival trend of different tumor locations from 1960s to 2000s.

Authors:  Yu-Jing Fang; Xiao-Jun Wu; Qian Zhao; Li-Ren Li; Zhen-Hai Lu; Pei-Rong Ding; Rong-Xin Zhang; Ling-Heng Kong; Fu-Long Wang; Jun-Zhong Lin; Gong Chen; Zhi-Zhong Pan; De-Sen Wan
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

View more
  11 in total

Review 1.  Role of secretory clusterin in hepatocarcinogenesis.

Authors:  Min Yao; Miao Fang; Wenjie Zheng; Zhizhen Dong; Dengfu Yao
Journal:  Transl Gastroenterol Hepatol       Date:  2018-08-01

Review 2.  Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma.

Authors:  Min Yao; Jun-Ling Yang; De-Feng Wang; Li Wang; Ying Chen; Deng-Fu Yao
Journal:  World J Clin Cases       Date:  2022-04-16       Impact factor: 1.534

3.  Genomic and Molecular Characterization of Brain Tumors in Asian and Non-Asian Patients of Los Angeles: A Single Institution Analysis.

Authors:  Courtney Duong; Thien Nguyen; John P Sheppard; Vera Ong; Lawrance K Chung; Daniel T Nagasawa; Isaac Yang
Journal:  Brain Tumor Res Treat       Date:  2017-10-31

4.  High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Wenjie Zheng; Junling Yang; Zhizhen Dong; Li Wang; Miao Fang; Wei Wu; Dengfu Yao; Min Yao
Journal:  Cancer Manag Res       Date:  2018-11-20       Impact factor: 3.989

5.  Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma.

Authors:  Wenjie Zheng; Min Yao; Miao Fang; Liuhong Pan; Li Wang; Junling Yang; Zhizhen Dong; Dengfu Yao
Journal:  J Cancer       Date:  2019-10-08       Impact factor: 4.207

6.  Association of cancer screening and residing in a coal-polluted East Asian region with overall survival of lung cancer patients: a retrospective cohort study.

Authors:  Runxiang Yang; Ming He; Dongmei Wang; Rongrong Ye; Lu Li; Rouyu Deng; Mohsin Shah; Sai-Ching Jim Yeung
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

Review 7.  Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data.

Authors:  Yufei Jiang; Huiyun Yuan; Zhuoying Li; Xiaowei Ji; Qiuming Shen; Jiayi Tuo; Jinghao Bi; Honglan Li; Yongbing Xiang
Journal:  Cancer Biol Med       Date:  2021-09-06       Impact factor: 4.248

8.  Cancer survival in patients from a hospital-based cancer registry, China.

Authors:  Jian-Guo Chen; Hai-Zhen Chen; Jian Zhu; Yan-Lei Yang; Yong-Hui Zhang; Pei-Xin Huang; Yong-Sheng Chen; Chao-Yong Zhu; Li-Ping Yang; Kang Shen; Fu-Lin Qiang; Gao-Ren Wang
Journal:  J Cancer       Date:  2018-02-12       Impact factor: 4.207

9.  Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth.

Authors:  Meng-Na Wu; Wen-Jie Zheng; Wen-Xin Ye; Li Wang; Ying Chen; Jie Yang; Deng-Fu Yao; Min Yao
Journal:  World J Gastroenterol       Date:  2021-06-21       Impact factor: 5.742

10.  Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis.

Authors:  Zijie Wang; Hongliang Que; Chuanjian Suo; Zhijian Han; Jun Tao; Zhengkai Huang; Xiaobin Ju; Ruoyun Tan; Min Gu
Journal:  Oncotarget       Date:  2017-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.